secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001628280-24-021310
Event type: earnings
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics posts Q1 2024 earnings supplemental materials; no financial data provided in filing excerpt
--------------------------------------------------------------------------------

- Furnished investor presentation for Q1 2024 earnings results on May 7, 2024.
- Presentation available on company website; content not fully reproduced in the filing.
- No specific revenue, EPS, or guidance figures visible in the provided excerpt.
- Item 7.01 disclosure with Exhibit 99.1; deemed furnished, not filed.
- Company trades on Nasdaq under ticker AQST.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024021310/0001628280-24-021310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024021310/aqst-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-021310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer